Testosterone levels have declined in men. Here's what the FDA wants to do about it

"A Food and Drug Administration panel of health experts convened Wednesday to discuss and promote the health benefits of testosterone treatments for men. FDA Commissioner Martin Makary told Morning Edition that low testosterone is believed to be associated with symptoms in roughly one-third of men who have it, though he said the evidence and data are not fully defined. Symptoms can include "reduction in mood and vitality," Makary said."

"Speaking to NPR's Steve Inskeep, Makary discussed why the FDA wants to reconsider medical access to testosterone and the stigma associated with its use. Listen to the full conversation by clicking the blue play button above. The radio version of this story was edited by Adam Bearne and produced by Lilly Quiroz. The web copy was written by Obed Manuel and edited by Majd Al-Waheidi."

An FDA panel of health experts convened to consider promoting the health benefits of testosterone treatments for men and to reevaluate medical access. FDA Commissioner Martin Makary indicated low testosterone is believed to be associated with symptoms in roughly one-third of men who have it, while noting that evidence and data are not fully defined. Reported symptoms include reduction in mood and vitality. The agency is examining the balance between potential therapeutic benefits and stigma surrounding testosterone use as it reassesses guidelines and access pathways. Officials emphasized the need for clearer data to define which patients may benefit and to guide safe prescribing.

Read at www.npr.org